TLDR
- SPCX shares advanced 1% in Thursday’s premarket session to $193.75, recovering from Wednesday’s inaugural decline of 5% to $191.82
- Shares remain 42% above the company’s $135 initial public offering price from June 12
- The Zephirin Group established a $310 valuation, highlighting constrained liquidity with approximately 640 million shares in circulation
- Arete’s Andrew Beale leads with a $401 projection, implying a ~$5.3 trillion market capitalization
- Current Wall Street coverage includes six analysts with valuations spanning $63 (Morningstar) through $401 (Arete), averaging $156
Shares of SpaceX (SPCX) recovered ground Thursday morning following the company’s inaugural post-IPO downturn. Trading in premarket hours showed a 1% increase to $193.75, rebounding from Wednesday’s 5% decline that settled at $191.82.
Space Exploration Technologies Corp., SPCX
Despite recent volatility, SPCX continues trading 42% higher than its $135 offering price. The equity had previously surged to $225.64—representing a 67% appreciation—across three straight sessions of gains before Wednesday’s reversal.
The Wednesday selloff coincided with broader market weakness. The Nasdaq declined 1.3% following the Federal Reserve’s decision to maintain current interest rates alongside retail sales figures suggesting weakening consumer discretionary activity.
Two fresh analyst reports contributed to Thursday’s positive momentum. The Zephirin Group highlighted what it termed an “underappreciated supply-demand imbalance,” noting that merely 640 million shares are presently accessible for trading. This represents limited availability for the 300-plus index funds seeking SpaceX allocation. Zephirin established a $310 valuation.
Subsequently, Arete analyst Andrew Beale surpassed that figure with a $401 projection alongside a Buy recommendation. Beale identifies substantial opportunity in Starlink v3 satellites, featuring enhanced size and capabilities versus current generation hardware. The critical dependency: these satellites necessitate Starship launches, SpaceX’s advanced rocket platform still progressing toward complete commercial operations.
Beale’s $401 target implies a SpaceX valuation approaching $5.3 trillion, representing 80 times projected 2027 revenue.
What the Bulls Are Saying
Timothy Horan from Oppenheimer characterized SpaceX as “the only vertically integrated AI company with the required capital, data, LLMs, hardware, manufacturing and engineering talent.” He projects a possible $10 trillion total addressable market by 2035, with orbital data centers serving as the primary expansion catalyst.
KGI Securities launched coverage with an outperform rating and $227 target. Wolfe Research assigned a $175 price objective, also rating outperform.
Where the Bears Stand
Skepticism persists at current valuation levels. CFRA’s Keith Snyder initiated with a sell rating and $115 target price. His primary apprehension: SpaceX’s substantial dependence on Starship, which hasn’t achieved complete commercial certification.
Snyder noted that postponements or technical obstacles with Starship “could ripple across nearly every major growth initiative.” He additionally raised concerns regarding the company’s capital-intensive operations and free cash flow generation.
Morningstar holds the most conservative view at $63, constructing three scenarios for the artificial intelligence business segment. Even within their optimistic “moonshot” scenario, SpaceX would require a 77% probability of overcoming engineering challenges and executing multiple weekly Starship launches to warrant the $135 offering price.
The six analysts presently tracking SPCX demonstrate an average consensus target of $156—significantly beneath the stock’s current trading level near $208 based on recent data.
With derivatives trading now launched and passive fund accumulation underway, supply-demand mechanics are exerting disproportionate influence on near-term price movement.
